Trxade Group (MEDS)
NASDAQ:MEDS

Trxade Group (MEDS) Stock Investors

148 Followers
Based on 748,140 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold MEDS
On average, investors allocate 0.00% of their portfolios to MEDS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 748,140 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding MEDS

6.5%
Last 7
Days
11.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding MEDS, out of 748,140 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

MEDS Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.51%
$12.14
Based on the activity of 14,205 investors who made their portfolios public
The table shows changes in MEDS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

MEDS Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
AMC Entertainment
5.77%
-1.01%
-4.01%
1.56B
Communication Services
Blink Charging Co
5.21%
-1.22%
-4.68%
314.30M
Industrials
ChargePoint Holdings
4.18%
-1.03%
-2.53%
850.61M
Consumer Cyclical
Coherus Biosciences
2.59%
-1.51%
-5.49%
195.03M
Healthcare
Marathon Digital Holdings
5.70%
+0.23%
+0.92%
6.54B
Financial
DraftKings
5.79%
-0.56%
-1.68%
32.33B
Consumer Cyclical
GE Aerospace
5.21%
+0.33%
+1.54%
178.16B
Industrials
Riot Platforms
5.12%
-0.23%
+0.55%
3.53B
Financial
Bristol-Myers Squibb
3.22%
-0.69%
+1.52%
86.50B
Healthcare
Plug Power
5.00%
-1.14%
-3.27%
1.86B
Industrials
Based on the activity of 748,140 active portfolios
Open your Smart Portfolio

MEDS Investor Analysis

MEDS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
40.0%
of MEDS holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
MEDS investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
35.0%
of MEDS holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
MEDS investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
25.0%
of MEDS holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of MEDS stock investors
See who invests in MEDS according to age group and performance.

FAQ

How many retail Investors hold MEDS?
<0.1% of TipRanks' retail investors hold MEDS in their portfolios.
    What is MEDS Investor Sentiment?
    MEDS’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of MEDS in the last 7 days?
      ▲ 6.5% of TipRanks' retail investors changed their holding of MEDS in the last 7 days.
        What percentage of retail investors changed their holding of MEDS in the last 30 days?
        ▲ 11.3% of TipRanks' retail investors changed their holding of MEDS in the last 30 days.
          What is the average age of retail investors who hold MEDS?
          The average age of MEDS Holders is under 35.
            What other stocks have MEDS investors also bought?
            MEDS Investors also bought AMC, BLNK, CHPT, CHRS, MARA, DKNG, GE, RIOT, BMY, PLUG.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BCRXBioCryst
              CRLCharles River Labs
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis